Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Business Today

The company had a net loss of Rs 521.70 crore in the same period last fiscal, Dr Reddy's Laboratories said in a statement.

 
 
Biocon posted a growth rate of 24.55 per cent in net profit at Rs 100.75 crore for the third qaurter ended December 31, 2010.
Drug firm Cipla on Tuesday said it has received fresh notices from National Pharmaceutical Pricing Authority (NPPA) for Rs 73.16 crore for overpricing of two drugs.
The 913.5-million rand order bagged by Sonke Pharmaceuticals is a part of a 4.28 billion rand national anti-retroviral (ARV) tender floated by the African government.
Both India and China are expected to propel the global pharma market to Rs 5.13 lakh crore ($1.1 trillion) by 2014.

The company shareholders, through a postal ballot, had approved the buy back of 4.18 crore shares of the firm from shareholders on a proportionate basis.
 
 
In a separate filing to the BSE, Max India announced it had sought shareholders' approval for investing Rs 750 crore in Max Healthcare only as an enabling resolution.
The sector clocked a sales increase of over 18 per cent over the past two quarters but a chunk of this 'growth' has come about because of rising drug prices.
The firm's Bollaram manufacturing facility produces active pharmaceutical ingredients. Police said the victims at the company's facility were on night duty.
As part of the deal, Reckitt will buy 63 per cent stake of emerging markets private equity investor Actis, Sequoia Capital and that of the remaining shareholders.
Vishal Bali has spent 19 years running the Wockhardt Hospitals Group in India, until acquisition of its substantive assets (10 Hospitals) by Fortis in 2009.
Advertisement